Skip to main content

Roles of aggregating proteins and molecular chaperones in the immune dysregulation linked to misfolding neurodegenerative disease

RYC-2017-23127

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers

  • Mannini, Benedetta
  • Vecchi, Giulia
  • Labrador-Garrido, Adahir
  • Fabre, Bertrand
  • Fani, Giulia
  • Franco, Jaime M.
  • Lilley, Kathryn
  • Pozo, David
  • Vendruscolo, Michele
  • Chiti, Fabrizio
  • Dobson, Christopher M.
  • Roodveldt, Cintia
The formation of misfolded protein oligomers during early stages of amyloid aggregation and the activation of neuroinflammatory responses are two key events associated with neurodegenerative diseases. Although it has been established that misfolded oligomers are involved in the neuroinflammatory process, the links between their structural features and their functional effects on the immune response remain unknown. To explore such links, we took advantage of two structurally distinct soluble oligomers (type A and B) of protein HypF-N and compared the elicited microglial inflammatory responses. By using confocal microscopy, protein pull-down, and high-throughput mass spectrometry, we found that, even though both types bound to a common pool of microglial proteins, type B oligomers - with a lower solvent-exposed hydrophobicity - showed enhanced protein binding, correlating with the observed inflammatory response. Furthermore, the interactome associated with inflammatory-mediated neurodegeneration revealed previously unidentified receptors and signaling molecules likely to be involved in the oligomer-elicited innate immune response., Financial support was provided by FEBS (Short-Term Fellowship to B.M.), EMBO (ASTF 450-2013 to B.M.), the Italian Society of Biochemistry and Molecular Biology (B.M.), the Spanish Ministry of Economy (RTC-2015-3309-1 to C.R., ISCIII CPII16/58 to C.R., PI14-1600 to D.P., and RTI2018- 098432-B-I00 to C.R. and D.P.), the Regional Ministry of Economy (P11-CTS-8161 and PAIDI2020 CTS-677 to D.P.), Programa “Atraccion de Talento ́ ”, University of Seville, and Programa “Ramon y Cajal ́ ”, Spanish Ministry of Economy (RYC-2017-23127 to C.R.). This work was also supported by the Cambridge Centre for Misfolding Diseases (B.M., G.V., G.F., M.V., C.M.D.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Distinct responses of human peripheral blood cells to different misfolded protein oligomers

  • Leal-Lasarte, María M.
  • Mannini, Benedetta
  • Chiti, Fabrizio
  • Vendruscolo, Michele
  • Dobson, Christopher M.
  • Roodveldt, Cintia
  • Pozo, David
Increasing evidence indicates that peripheral immune cells play a prominent role in neurodegeneration connected to protein misfolding, which are associated with formation of aberrant aggregates, including soluble protein misfolded oligomers. The precise links, however, between the physicochemical features of diverse oligomers and their effects on the immune system, particularly on adaptive immunity, remain currently unexplored, due partly to the transient and heterogeneous nature of the oligomers themselves. To overcome these limitations, we took advantage of two stable and well-characterized types of model oligomers (A and B), formed by HypF-N bacterial protein, type B oligomers displaying lower solvent-exposed hydrophobicity. Exposure to oligomers of human peripheral blood mononuclear cells (PBMCs) revealed differential effects, with type B, but not type A, oligomers leading to a reduction in CD4 cells. Type A oligomers promoted enhanced differentiation towards CD4CD25FoxP3 Tregs and displayed a higher suppressive effect on lymphocyte proliferation than Tregs treated with oligomers B or untreated cells. Moreover, our results reveal Th1 and Th17 lymphocyte differentiation mediated by type A oligomers and a differential balance of TGF-β, IL-6, IL-23, IFN-γ and IL-10 mediators. These results indicate that type B oligomers recapitulate some of the biological responses associated with Parkinson's disease in peripheral immunocompetent cells, while type A oligomers resemble responses associated with Alzheimer's disease. We anticipate that further studies characterizing the differential effects of protein misfolded oligomers on the peripheral immune system may lead to the development of blood-based diagnostics, which could report on the type and properties of oligomers present in patients., Financial support was provided by the Spanish Ministry of Economy (RTI2018-098432-B-I00 to D.P. and C.R.), the Regional Ministry of Economy (PAIDI2020 CTS-677 to D.P.), Fundación ‘Ramón Areces’ (conv. 2018 to C.R.), Andalusian Regional Government-FEDER (US-1265227 to C.R.), Programa ‘Ramón y Cajal’ of the Spanish Ministry of Economy (RYC-2017-23127 to C.R.), FEBS (Short-Term Fellowship to B.M.), EMBO (ASTF 450-2013 to B.M.) and the Italian Society of Biochemistry and Molecular Biology (B.M.). This work was also supported by the Cambridge Centre for Misfolding Diseases, UK (B.M., M.V., C.M.D.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Immune signaling kinases in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)

  • García-García, Raquel
  • Martín-Herrero, Laura
  • Blanca-Pariente, Laura
  • Pérez-Cabello, Jesús Ángel
  • Roodveldt, Cintia
Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disorder of motor neurons in adults, with a median survival of 3–5 years after appearance of symptoms, and with no curative treatment currently available. Frontotemporal dementia (FTD) is also an adult-onset neurodegenerative disease, displaying not only clinical overlap with ALS, but also significant similarities at genetic and pathologic levels. Apart from the progressive loss of neurons and the accumulation of protein inclusions in certain cells and tissues, both disorders are characterized by chronic inflammation mediated by activated microglia and astrocytes, with an early and critical impact of neurodegeneration along the disease course. Despite the progress made in the last two decades in our knowledge around these disorders, the underlying molecular mechanisms of such non-cell autonomous neuronal loss still need to be clarified. In particular, immune signaling kinases are currently thought to have a key role in determining the neuroprotective or neurodegenerative nature of the central and peripheral immune states in health and disease. This review provides a comprehensive and updated view of the proposed mechanisms, therapeutic potential, and ongoing clinical trials of immune-related kinases that have been linked to ALS and/or FTD, by covering the more established TBK1, RIPK1/3, RACK I, and EPHA4 kinases, as well as other emerging players in ALS and FTD immune signaling., Financial support to C.R. has been granted by the Spanish Ministry of Economy (RTI2018- 098432-B-I00), Fundación ‘Ramón Areces’ (CIVP19A5938), Andalusian Regional Government-FEDER (US-1265227) and I+D PAIDI (PY20_01097), and ‘Programa Ramón y Cajal’ of the Spanish Ministry of Economy (RYC-2017-23127).